维普期刊资源整合服务平台（V6.5）

90篇 您的检索式：作者名="PARNETTI L"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Idebenone in senile dementia of Alzheimer type : a multicentre study显示文摘	Senin U Parnetti L Barbagallo-Sangiorgi G	1992	Arch Gerontol Geriatr1992，15，3：	1
2	Pharmacokinetics of iv and oral acetyl-1-carnitine in a multiple dose regimen in pa- tients with senile dementia of alzheimer type 显示文摘	Parnetti L Gaiti A Mecocci P	1992	Eur J Clin Pharmacol1992，42，1：	1
3	Multi-centre study of L-alpha glyceryl-phosphorylcholine vsST200 among patients with probable senile dementia ofAlzheimer’s type显示文摘	PARNETTI L ABATE G BARTORELLI L	1993	Drugs Aging1993，3，2：	1
4	Mild hyperhomocysteinemia is a risk factor in all etiological subtypes of stroke显示文摘	Parnetti L Caso V Santucci A	2004	Neurol Sci2004，25，1：	1
5	Hyperhomocysteinemia:a risk factor for cerebrovascular disease显示文摘	Parnetti L Caso V Amici S	2002	Clin Exp Hypertens2002，24，78：	1
6	Clinical pharmacokinetics of drugs for Alzheimer's disease 显示文摘	Parnetti L	1995	Clin Pharmacokinet1995，29，2：	1
7	Early admission to stroke unit influences clinical outcome显示文摘	Silvestrelli G Parnetti L Paciaroni M	2006	Eur J Neurol2006，13，3：	1
8	Cognitive enhancement therapy for Alzheimer's disease显示文摘	Parnetti L Senin U Mecocci P	1997	Drugs1997，53，8：	1
9	Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers显示文摘	Parnetti L Lanari A Silvestrelli G	2006	Mech Ageing Dev2006，127，：	1
10	Treatment of Alzheimer's disease:From pharmacology to a better understanding of disease pathophysiology显示文摘	Silvestrelli G Lanari A Parnetti L	2006	Mech Ageing Dev2006，127，2：	1
11	CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies显示文摘	Parnetti L Lanari A Amici S	2001	Neurol Sci2001，22，：	1
12	Early admission to stroke unit im'luences clinical outcome 显示文摘	Silvestrelli G Parnetti L Paciaroni M	2006	Eur J Neurol2006，13，：	1
13	Multicentre study of L-alpha-glyeerylphosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type 显示文摘	Parnetti L Abate G Bartorelli L	1993	Drugs Aging1993，3，2：	1
14	Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke显示文摘	Parnetti L Caso V Santucci A	2004	Neurol Sci2004，25，：	1
15	Cognitive en2hancement therapy for Alzheimer's disease显示文摘	Senin U and Necocci P	1997	Drugs1997，53，5：	1
16	Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group显示文摘	Parnetti L Meeocci P Petrini A	1989	Neuropsychobiology1989，22，2：	1
17	Treatment of Alzheimer' s disease: from pharmacology to a better understanding of disease pathophysiology显示文摘	Silvestrelli G Lanari A Parnetti L	2006	Mech Ageing Dev2006，127，：	1
18	Arterial hypertension and stroke prevention: an update显示文摘	Bornstein N Silvestrelli G Caso V Parnetti L	2006	Clin Exp Hypertens2006，28，34：	1
19	Cerebrospinal fluid biomarmarkers in Parkinson disease显示文摘	Parnetti L Castrioto A Chiasserini D	2013	Nat Rev Neurol2013，9，：	1
20	Cholinergie precursors in the treatment of cognitive impairment of vascular origin:ineffective approaches or need for reevaluation 显示文摘	Parnetti L Mignini F Tomassoni D		J Neurol Sci0，257，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示